Role of LRP in TGFβ2-mediated neuronal uptake of Aβ and effects on memory

Journal of Neuroscience Research

Volumn 77, Issue 2, 2004, Pages 217-228

  Harris White, Marni E ^a,c   Balverde, Zerlinde ^c   Lim, Giselle P ^a   Kim, Peter ^a   Miller, Sheryl A ^a   Hammer, Heidi ^a   Galasko, Doug ^d   Frautschy, Sally A ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Amyloid; In vivo; LDL receptor related protein; Morris water maze; Transforming growth factor 2

Indexed keywords

AMYLOID BETA PROTEIN; LOW DENSITY LIPOPROTEIN RECEPTOR RELATED PROTEIN; PROTEIN; RECEPTOR RELATED PROTEIN; TRANSFORMING GROWTH FACTOR BETA2; UNCLASSIFIED DRUG; LOW DENSITY LIPOPROTEIN RECEPTOR RELATED PROTEIN ASSOCIATED PROTEIN; TRANSFORMING GROWTH FACTOR BETA;

ALZHEIMER DISEASE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN SLICE; CELL MEMBRANE TRANSPORT; CONTROLLED STUDY; HIPPOCAMPUS; HUMAN; IN VITRO STUDY; IN VIVO STUDY; MAZE TEST; MEMORY; MEMORY CONSOLIDATION; MEMORY DISORDER; MOUSE; NERVE CELL; NERVE DEGENERATION; NEUROPATHOLOGY; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN TARGETING; PROTEIN TRANSPORT; ANIMAL; C57BL MOUSE; DRUG ANTAGONISM; INSTITUTE FOR CANCER RESEARCH MOUSE; METABOLISM; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY;

ALZHEIMER DISEASE; AMYLOID BETA-PROTEIN; ANIMALS; HIPPOCAMPUS; LDL-RECEPTOR RELATED PROTEIN 1; LDL-RECEPTOR RELATED PROTEIN-ASSOCIATED PROTEIN; MEMORY DISORDERS; MICE; MICE, INBRED C57BL; MICE, INBRED ICR; NERVE DEGENERATION; NEURONS; PROTEIN TRANSPORT; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA2;

EID: 3042707731     PISSN: 03604012     EISSN: None     Source Type: Journal    
DOI: 10.1002/jnr.20149     Document Type: Article

References (91)

1. Arelin K, Kinoshita A, Whelan CM, Irizarry MC, Rebeck GW, Strickland DK, Hyman BT. 2002. LRP and senile plaques in Alzheimer's disease: colocalization with apolipoprotein E and with activated astrocytes. Brain Res Mol Brain Res 104:38-46.
2. Baum L, Chen L, Ng HK, Chan YS, Mak YT, Woo J, Chiu HFK, Pang CP. 1998. Low density lipoprotein receptor related protein gene exon 3 polymorphism association with Alzheimer's disease in Chinese. Neurosci Lett 247:33-36.
3. Beffert U, Aumont N, Dea D, Lussier-Cacan S, Davignon J, Poirier J. 1998. Beta-amyloid peptides increase the binding and internalization of apolipoprotein E to hippocampal neurons. J Neurochem 70:1458-1466.
4. Blacker D, Wilcox MA, Laird NM, Rodes L, Horvath SM, Go RC, Perry R, Watson B Jr, Bassett SS, McInnis MG, Albert MS, Hyman BT, Tanzi RE. 1998. Alpha-2 macroglobulin is genetically associated with Alzheimer disease. Nat Genet 19:357-360.
5. Bodmer S, Podlisny MB, Selkoe DJ, Heid I, Fontana A. 1990. Transforming growth factor-β bound to soluble derivatives of the β-amyloid precursor protein of Alzheimer's disease. Biochem Biophys Res Commun 171:890-897.
6. Borth W. 1992. Alpha 2-macroglobulin, a multifunctional binding protein with targeting characteristics. FASEB J 6:3345-3353.
7. Bu G. 1998. Receptor-associated protein: a specialized chaperone and antagonist for members of the LDL receptor gene family. Curr Opin Lipidol 9:149-155.
8. Causevic M, Ramoz N, Haroutunian V, Davis KL, Buxbaum JD. 2003. Lack of association between the levels of the low-density lipoprotein receptor-related protein (LRP) and either Alzheimer dementia or LRP exon 3 genotype. J Neuropathol Exp Neurol 62:999-1005.
9. Chao CC, Hu S, Frey WH, Ala TA, Tourtellotte WW, Peterson PK. 1994. Transforming growth factor β in Alzheimer's disease. Clin Diagn Lab Immunol 1:109-110.
10. Clayton DA, Mesches MH, Alvarez E, Bickford PC, Browning MD. 2002. A hippocampal NR2B deficit can mimic age-related changes in long-term potentiation and spatial learning in the Fischer 344 rat. J Neurosci 22:3628-3637.
11. Constam DB, Philipp J, Malipiero UV, ten Dijke P, Schachner M, Fontana A. 1992. Differential expression of transforming growth factor-beta1, -beta2, and -beta3 by glioblastoma cells, astrocytes, and microglia. J Immunol 148:1404-1410.
12. D'Andrea MR, Nagele RG, Wang HY, Peterson PA, Lee DHS. 2001. Evidence that neurones accumulating amyloid can undergo lysis to form amyloid plaques in Alzheimer's disease. Histopathology 38:120-134.
13. De Ferrari GV, Chacon MA, Barria MI, Garrido JL, Godoy JA, Olivares G, Reyes AE, Alvarez A, Bronfinan M, Inestrosa NC. 2003. Activation of Wnt signaling rescues neurodegeneration and behavioral impairments induced by beta-amyloid fibrils. Mol Psychiatry 8:195-208.
14. del Rio-Hortega P. 1932. Microglia. In: Penfield W, editor. Cytology and cellular pathology of the nervous system. New York: Hoeber. p 483-534.
15. Du Y, Ni B, Glinn M, Dodel RC, Bales KR, Zhang Z, Hyslop PA, Paul SM. 1997. α2-Macroglobulin as a beta-amyloid peptide-binding plasma protein. J Neurochem 69:299-305.
16. Duclert A, Changeux JP. 1995. Acetylcholine receptor gene expression at the developing neuromuscular junction. Physiol Rev 75:339-368.
17. Flanders KC, Lippa CF, Smith TW, Pollen DA, Sporn MB. 1995. Altered expression of transforming growth factor-beta in Alzheimer's disease. Neurology 45:1561-1569.
18. Frautschy SA, Calderon L, Yang F, Cole GM. 1996. Rodent models of Alzheimer's disease: a comparison of transgenic APP mouse and rat A beta infusion approaches. Neurobiol Aging 17:311-321.
19. Frautschy SA, Horn DL, Sigel JJ, Harris-White ME, Mendoza JJ, Yang FS, Saido TC, Cole GM. 1998. Protease inhibitor coinfusion with amyloid beta-protein results in enhanced deposition and toxicity in rat brain. J Neurosci 18:8311-8321.
20. Frautschy SA, Hu W, Kim P, Miller SA, Chu T, Harris-White ME, Cole GM. 2001. Phenolic anti-inflammatory antioxidant reversal of A beta-induced cognitive deficits and neuropathology. Neurobiol Aging 22:993-1005.
21. Gallagher M, Burwell R, Burchinal M. 1993. Severity of spatial learning impairment in aging: development of a learning index for performance in the Morris water maze. Behav Neurosci 107:618-626.
22. Gotthardt M, Trommsdorff M, Nevitt MF, Shelton J, Richardson JA, Stockinger W, Nimpf J, Herz J. 2000. Interactions of the low density lipoprotein receptor gene family with cytosolic adaptor and scaffold proteins suggest diverse biological functions in cellular communication and signal transduction. J Biol Chem 275:25616-25624.
23. Gracia V, Fiol C, Hurtado I, Pinto X, Argimon JM, Castineiras Mj. 1994. An enzyme-linked immunosorbent assay method to measure human apolipoprotein E levels using commercially available reagents: effect of apolipoprotein E polymorphism on serum apolipoprotein E concentration. Anal Biochem 223:212-217.
24. Gylys KH, Fein JA, Tan AM, Cole GM. 2003. Apolipoprotein E enhances uptake of soluble but not aggregated amyloid-beta protein into synaptic terminals. J Neurochem 84:1442-1451.
25. Harris-White ME, Chu T, Balverde Z, Sigel JJ, Flanders KC, Frautschy SA. 1998. Effects of transforming growth factor-beta (isoforms 1-3) on amyloid-beta deposition, inflammation, and cell targeting in organotypic hippocampal slice cultures. J Neurosci 18:10366-10374.
26. Herz J, Hamann U, Rogne S, Myklebost O, Gausepohl H, Starley KK. 1988. Surface location and high affinity for calcium of a 500-kd liver membrane protein closely related to the LDL-receptor suggest a physiological role as lipoprotein receptor. EMBO J 7:4119-4127.
27. Hollenbach E, Ackermann S, Hyman BT, Rebeck GW. 1998. Confirmation of an association between a polymorphism in exon 3 of the low-density lipoprotein receptor-related protein gene and Alzheimer's disease. Neurology 50:1905-1907.
28. Holtzman DM, Pitas RE, Kilbridge J, Nathan B, Mahley RW, Bu G, Schwartz AL. 1995. Low density lipoprotein receptor-related protein mediates apolipoprotein E-dependent neurite outgrowth in a central nervous system-derived neuronal cell line. Proc Natl Acad Sci USA 92:9480-9484.
29. Huang SS, Ling TY, Tseng WF, Huang YH, Tang FM, Leal SM, Huang JS. 2003. Cellular growth inhibition by 1GFBP-3 and TGF-beta1 requires LRP-1. FASEB J 17:2068-2081.
30. Hussaini IM, Lamarre J, Lysiak JJ, Karns LP, VandenBerg SR, Gonias SL. 1996. Transcriptional regulation of LDL receptor-related protein by IFN-gamma and the antagonistic activity of TGF-beta(1) in the RAW 264.7 macrophage-like cell line. J Leukoc Biol 59:733-739.
31. Iqbal K, Alonso AC, Gong CX, Khatoon S, Singh TJ, Grundke-Iqbal I. 1994. Mechanism of neurofibrillary degeneration in Alzheimer's disease. Mol Neurobiol 9:119-123.
32. Ji ZS, Pitas RE, Mahley RW. 1998. Differential cellular accumulation/retention of apolipoprotein E mediated by cell surface heparan sulfate proteoglycans. Apolipoproteins E3 and E2 greater than E4. J Biol Chem 273:13452-13460.
33. Kamboh MI, Ferrell RE, DeKosky ST. 1998. Genetic association studies between Alzheimer's disease and two polymorphisms in the low density lipoprotein receptor-related protein gene. Neurosci Lett 244:65-68.
34. Kang DE, Pietrzik CU, Baum L, Chevallier N, Merriam DE, Kounnas MZ, Wagner SL, Troncoso JC, Kawas CH, Katzman R, Koo EH. 2000. Modulation of amyloid beta-protein clearance and Alzheimer's disease susceptibility by the LDL receptor-related protein pathway. J Clin Invest 106:1159-1166.
35. Kang DE, Saitoh T, Chen X, Xia Y, Masliah E, Hansen LA, Thomas RG, Thal LJ, Katzman R. 1997. Genetic association of the low-density lipoprotein receptor-related protein gene (LRP), an apolipoprotein E receptor, with late-onset Alzheimer's disease. Neurology 49:56-61.
36. Kim HJj, Chae SC, Lee DK, Chromy B, Lee SC, Park YC, Klein WL, Krafft GA, Hong ST. 2003. Selective neuronal degeneration induced by soluble oligomeric amyloid beta protein. FASEB J 17:118-120.
37. Klempt ND, Sirimanne E, Gunn AJ, Klempt M, Singh K, Williams C, Gluckman PD. 1992. Hypoxia-ischemia induces transforming growth factor beta 1 mRNA in the infant rat brain. Brain Res Mol Brain Res 13:93-101.
38. Kounnas MZ, Moir RD, Rebeck GW, Bush AI, Argraves WS, Tanzi RE, Hyman BT, Strickland DK. 1995. LDL receptor-related protein, a multifunctional ApoE receptor, binds secreted beta-amyloid precursor protein and mediates its degradation. Cell 82:331-340.
39. Krieglstein K, Rufer M, Suter-Crazzolara C, Unsicker K. 1995. Neural functions of the transforming growth-factors-beta. Int J Dev Neurosci 13:301-315.
40. Ladu MJ, Falduto MT, Manelli AM, Reardon CA, Getz GS, Frail DE. 1994. Isoform-specific binding of apolipoprotein E to beta-amyloid. J Biol Chem 269:23403-23406.
41. LaFerla FM, Troncoso JC, Strickland DK, Kawas CH, Jay G. 1997. Neuronal cell death in Alzheimer's disease correlates with apoE uptake and intracellular Abeta stabilization. J Clin Invest 100:310-320.
42. Lambert JC, Wavrant-De Vrieze F, Amouyel P, Chartier-Harlin MC, 1998. Association at LRP gene locus with sporadic late-onset Alzheimer's disease. Lancet 351:1787-1788.
43. Laping NJ, Morgan TE, Nichols NR, Rozovsky I, Young-Chan CS, Zarow C, Finch CE. 1994. Transforming growth factor-beta 1 induces neuronal and astrocyte genes: tubulin alpha 1, glial fibrillary acidic protein and clusterin. Neuroscience 58:563-572.
44. Lesne S, Docagne F, Gabriel C, Liot G, Lahiri DK, Buee L, Plawinski L, Delacourte A, MacKenzie ET, Buisson A, Vivien D. 2003. Transforming growth factor-beta 1 potentiates amyloid-beta generation in astrocytes and in trarisgenic mice. J Biol Chem 278:18408-18418.
45. Lim GP, Yang F, Chu T, Chen P, Beech W, Teter B, Tran T, Ubeda O, Ashe KH, Frautschy SA, Cole GM. 2000. Ibuprofen suppresses plaque pathology and inflammation in a mouse model for Alzheimer's disease. J Neurosci 20:5709-5714.
46. Lindholm D, Castren E, Kiefer R, Zafra F, Thoenen H. 1992. Transforming growth factor-beta 1 in the rat brain: increase after injury and inhibition of astrocyte proliferation. J Cell Biol 117:395-400.
47. Lippa CF, Smith TW, Flanders KC. 1995. Transforming growth factor-β: neuronal and glial expression in CNS degenerative diseases. Neurodegeneration 4:425-432.
48. Logan A, Frautschy SA, Gonzalez A-M, Sporn MB, Baird A. 1992. Enhanced expression of transforming growth factor B1 in the rat brain after a localized cerebral injury. Brain Res 587:216-225.
49. Lucas FR, Goold RG, Gordon-Weeks PR, Salinas PC. 1998. Inhibition of GSK-3beta leading to the loss of phosphorylated MAP-1B is an early event in axonal remodelling induced by WNT-7a or lithium. J Cell Sci 111:1351-1361.
50. Mahley RW, Nathan BP, Bellosta S, Pitas RE. 1995. Apolipoprotein E: impact of cytoskeletal stability in neurons and the relationship to Alzheimer's disease. Curr Opin Lipidol 6:86-91.
51. Mandelkow EM, Biernat J, Drewes G, Steiner B, Lichtenberg-Kraag B, Wille H, Gustke N, Mandelkow E. 1993. Microtubule-associated protein tau, paired helical filaments, and phosphorylation. Ann N Y Acad Sci 695:209-216.
52. Mazur-Kolecka B, Frackowiak J, Le Vine H 3rd, Haske T, Evans L, Sukontasup T, Golabek A. 2003. TGFbeta1 enhances formation of cellular Abeta/apoE deposits in vascular myocytes. Neurobiol Aging 24:355-364.
53. McIlroy SP, Dynan KB, Vahidassr DJ, Lawson JT, Patterson CC, Passmore P. 2001. Common polymorphisms in LRP and A2M do not affect genetic risk for Alzheimer disease in Northern Ireland. Am J Med Genet 105:502-506.
54. McLennan IS, Koishi K. 1994. Transfomling growth factor-beta-2 (TGF-beta-2) is associated with mature rat neuromuscular junctions. Neurosci Lett 177:151-154.
55. McLennan IS, Koishi K, Zhang M, Murakami N. 1998. The non-synaptic expression of transforming growth factor-beta 2 is neurally regulated and varies between skeletal muscle fibre types. Neuroscience 87:845-853.
56. Minetti A, Arolfo MP, Virgolini MB, Brioni JD, Fulginiti S. 1996. Spatial learning in rats exposed to acute ethanol intoxication on gestational day 8. Pharmacol Biochem Behav 53:361-367.
57. Mousseau DD, Chapelsky S, De Crescenzo G, Kirkitadze MD, Magoon J, Inoue S, Teplow DB, O'Connor-McCourt MD. 2003. A direct interaction between transforming growth factor (TGF)-betas and amyloid-beta protein affects fibrillogenesis in a TGF-beta receptor-independent manner. J Biol Chem 278:38715-38722.
58. Murakami N, McLennan IS, Nonaka I, Koishi K, Baker C, Hammond-Tooke G. 1999. Transfonrming growth factor-beta 2 is elevated in skeletal muscle disorders. Muscle Nerve 22:889-898.
59. Nakamura S, Murayama N, Noshita T, Annoura H, Ohno T. 2001. Progressive brain dysfunction following intracerebroventricular infusion of beta(1-42)-amyloid peptide. Brain Res 912:128-136.
60. Narita M, Holtzman DM, Schwartz AL, Bu G. 1997. α2-Macroglobulin complexes with and mediates the endocytosis of beta-amyloid peptide via cell surface low-density lipoprotein receptor-related protein. J Neurochem 69:1904-1911.
61. Nathan BP, Chang K-C, Bellosta S, Brisch E, Ge N, Mahley RW, Pitas RE. 1995. The inhibitory effect of apolipoprotein E4 on neurite out-growth is associated with microtubule depolymerization. J Biol Chem 270:19791-19799.
62. Pelton RW, Saxena B, Jones M, Moses HL, Gold LI. 1991. Immunohistochemical localization of TGF beta 1, TGF beta 2, and TGF beta 3 in the mouse embryo: expression patterns suggest multiple roles during embryonic development. J Cell Biol 115:1091-1105.
63. Peress NS, Perillo E. 1995. Differential expression of TGF-β1, 2 and 3 isotypes in Alzheimer's disease: a comparative immunohistochemical study with cerebral infarction, aged human and mouse control brains. J Neuropathol Exp Neurol 54:802-811.
64. Rebeck GW, Harr SD, Strickland DK, Hyman BT. 1995. Multiple, diverse senile plaque-associated proteins are ligands of an apolipoprotein E receptor, the alpha 2-macroglobulin receptor/low-density lipoprotein receptor-related protein. Ann Neurol 37:211-217.
65. Rebeck GW, Reiter JS, Strickland DK, Hyman BT. 1993. Apolipoprotein E in sporadic Alzheimer's disease: allelic variation and receptor interactions. Neuron 11:575-580.
66. Salinas PC. 2003. Synaptogenesis: Wnt and TGF-beta take centre stage. Curr Biol 13:60-62.
67. Sanchez-Guerra M, Combarros O, Infante J, Llorca J, Berciano J, Fontalba A, Fernandez-Luna JL, Pena N, Fernandez-Viadero C. 2001. Case-control study and meta-analysis of low density lipoprotein receptor-related protein gene exon 3 polymorphism in Alzheimer's disease. Neurosci Lett 316:17-20.
68. Sanford LP, Ormsby I, Gittenberger-de Groot AC, Sariola H, Friedman R, Boivin GP, Cardell EL, Doetschman T. 1997. TGFbeta2 knockout mice have multiple developmental defects that are non-overlapping with other TGFbeta knockout phenotypes. Development 124:2659-2670.
69. Schmued LC, Albertson C, Slikker W Jr. 1997. Fluoro-Jade: a novel fluorochrome for the sensitive and reliable histochemical localization of neuronal degeneration. Brain Res 751:37-46.
70. Schmued LC, Hopkins KJ. 2000. Fluoro-Jade B: a high affinity fluorescent marker for the localization of neuronal degeneration. Brain Res 874:123-130.
71. Schneider WJ, Nimpf J. 2003. LDL receptor relatives at the crossroad of endocytosis and signaling. Cell Mol Life Sci 60:892-903.
72. Selkoe DJ. 1994. Cell biology of the amyloid beta-protein precursor and the mechanism of Alzheimer's disease. Annu Rev Cell Biol 10:373-403.
73. Shie FS, LeBoeur RC, Jin LW. 2003. Early intraneuronal Abeta deposition in the hippocampus of APP transgenic mice. Neuroreport 14:123-129.
74. Shukitt-Hale B, McEwen JJ, Szprengiel A, Joseph JA. 2004. Effect of age on the radial arm water maze-a test of spatial learning and memory. Neurobiol Aging 25:223-229.
75. Stoppini L, Buchs PA, Muller D. 1991. A simple method for organotypic cultures of nervous tissue. J Neurosci Methods 37:173-182.
76. Strickland DK, Kounnas MZ, Argraves WS. 1995. LDL receptor-related protein: a multiligand receptor for lipoprotein and proteinase catabolism. FASEB J 9:890-898.
77. Strittmatter WJ, Saunders AM, Schmechel D, Pericak-Vance M, Enghild J, Salvesen GS, Roses AD. 1993. Apolipoprotein E: High-avidity binding to beta-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease. Proc Natl Acad Sci USA 90:1977-1981.
78. Tashiro H, Doh-ura K, Iwaki T. 1998. Differential expression of transforming growth factor-beta isoforms in human prion diseases. Neuropathol Appl Neurobiol 24:284-292.
79. Tuli R, Tuli S, Nandi S, Huang X, Manner PA, Hozack WJ, Danielson KG, Hall DJ, Tuan RS. 2003. TGF-beta 1-mediated chondrogenesis of human mesenchymal progenitor cells involves N-cadherin and MAP kinase and Wnt signaling crosstalk. J Biol Chem 278:41227-41236.
80. Van der Wal EA, Gomez-Pinilla F, Cotman CW. 1993. Transforming growth factor-beta1 is in plaques in Alzheimer and Down pathologies. Neuroreport 4:69-72.
81. van Groen T, Kadish I, Wyss JM. 2002. The role of the laterodorsal nucleus of the thalamus in spatial learning and memory in the rat. Behav Brain Res 136:329-337.
82. Vawter MP, Dillon-Carter O, Tourtellotte WW, Carvey P, Freed WJ. 1996. TGFbeta1 and TGFbeta2 concentrations are elevated in Parkinson's disease in ventricular cerebrospinal fluid. Exp Neurol 142:313-322.
83. Wavrant-DeVrieze F, Lambert JC, Stas L, Crook R, Cottel D, Pasquier F, Frigard B, Lambrechts M, Thiry E, Amouyel P, Tur JP, Chartier-Harlin MC, Hardy J, Van Leuven F. 1999. Association between coding variability in the LRP gene and the risk of late-onset Alzheimer's disease. Hum Genet 104:432-434.
84. Westerman MA, Cooper-Blacketer D, Mariash A, Kotilinek L, Kawarabayashi T, Younkin LH, Carlson GA, Younkin SG, Ashe KH. 2002. The relationship between Abeta and memory in the Tg2576 mouse model of Alzheimer's disease. J Neurosci 22:1858-1867.
85. Winkler J, Conner DJ, Frautschy SA, Behl C, Waite JJ, Cole GM, Thal LJ. 1994. Lack of long-term effects after β-amyloid protein injections in rat brain. Neurobiol Aging 15:601-607.
86. Wolf BB, Lopes MB, VandenBerg SR, Gonias SL. 1992. Characterization and immunohistochemical localization of alpha 2-macroglobulin receptor (low-density lipoprotein receptor-related protein) in human brain. Am J Pathol 141:37-42.
87. Wyss-Coray T, Lin C, Yan F, Yu GQ, Rohde M, McConlogue L, Masliah E, Mucke L. 2001. TGF-beta1 promotes microglial amyloid-beta clearance and reduces plaque burden in transgenic mice. Nat Med 7:612-618.
88. Wyss-Coray T, Masliah E, Mallory M, McConlogue L, Johnson-Wood K, Lin C, Mucke L. 1997. Amyloidogenic role of cytokine TGB-β1 in transgenic mice and in AD. Nature 389:603-606.
89. Yang AJ, Chandswangbhuvana D, Margol L, Glabe CG. 1998. Loss of endosomal/lysosomal membrane impermeability is an early event in amyloid A beta 1-42 pathogenesis. J Neurosci Res 52:691-698.
90. Yang F, Mak K, Vinters HV, Frautschy SA, Cole GM. 1994. Monoclonal antibody to the C-terminus of beta-amyloid. Neuroreport 5:2117-2120.
91. Zuckerman SH, Evans GF, O'Neal L. 1993. Exogenous glucocorticoids increase macrophage secretion of apo E by cholesterol-independent pathways. Atherosclerosis 103:43-54.